iTeos Therapeutics

Foundation date

01/08/2011

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients . We leverage our deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve the clinical benefit of oncology therapies.

Upcoming events

Latest news

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

  • Innovating today, creating tomorrow: the VIB Bio-Incubator

    Thursday April 18th 2024